![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 16, 7672-7677, 06, 1988
N Kaneda, H Ichinose, K Kobayashi, K Oka, F Kishi, A Nakazawa, Y Kurosawa, K Fujita and T Nagatsu
Department of Biochemistry, Nagoya University School of Medicine, Japan.
Phenylethanolamine N-methyltransferase (PNMT; EC 2.1.1.28) catalyzes the synthesis of epinephrine from norepinephrine, the last step of catecholamine biosynthesis. To isolate a cDNA clone for human PNMT, we first isolated a cDNA clone for bovine adrenal medulla PNMT using mixed oligodeoxyribonucleotide probes whose synthesis was based on the partial amino acid sequence of tryptic peptides from the bovine enzyme. By screening a bovine adrenal medulla cDNA library, a cDNA clone with an insert of about 200 base pairs (bp) was isolated. This clone consisted of 84 bp of carboxyl-terminal coding region, which contained amino acid sequences corresponding to two tryptic peptides, and about 100 bp of 3'-untranslated region. Using this cDNA fragment as the probe, we screened a human pheochromocytoma cDNA library and isolated a cDNA clone with an insert of about 1.0 kilobase pairs, which contained the complete coding region of the enzyme. Northern blot analysis of human pheochromocytoma poly(A)+ RNA using this cDNA insert as the probe showed a single RNA species of about 1,000 nucleotides, suggesting that this clone is a full-length cDNA. Determination of the nucleotide sequence revealed that human PNMT consists of 282-amino acid residues with a predicted molecular weight of 30,853, including initial methionine. The amino acid sequence of the human PNMT was highly homologous (88%) to that of the bovine enzyme. Chromosomal assignment of the gene for human PNMT was carried out using mouse-human somatic cell hybrids. The PNMT gene was assigned to chromosome 17.
This article has been cited by other articles:
![]() |
Y. Ji, E. M. Snyder, B. L. Fridley, O. E. Salavaggione, I. Moon, A. Batzler, V. C. Yee, D. J. Schaid, M. J. Joyner, B. D. Johnson, et al. Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release Physiol Genomics, May 9, 2008; 33(3): 323 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Tai, R. Claycomb, S. Her, A. K. Bloom, and D. L. Wong Glucocorticoid Responsiveness of the Rat Phenylethanolamine N-Methyltransferase Gene Mol. Pharmacol., June 1, 2002; 61(6): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Laffitte, H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, and P. A. Edwards Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor J. Biol. Chem., March 31, 2000; 275(14): 10638 - 10647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Her, R. A. Bell, A. K. Bloom, B. J. Siddall, and D. L. Wong Phenylethanolamine N-Methyltransferase Gene Expression. SP1 AND MAZ POTENTIAL FOR TISSUE-SPECIFIC EXPRESSION J. Biol. Chem., March 26, 1999; 274(13): 8698 - 8707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lohr, G. R. Willsky, and M. A. Acara Renal Drug Metabolism Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Koike, H. J. Jacob, J. E. Krieger, C. Szpirer, M. R. Hoehe, M. Horiuchi, and V. J. Dzau Investigation of the Phenylethanolamine N-Methyltransferase Gene as a Candidate Gene for Hypertension Hypertension, October 1, 1995; 26(4): 595 - 601. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |